HomeInsightsStock Comparison

Bliss Gvs Pharma Ltd vs Vivanza Biosciences Ltd Stock Comparison

Bliss Gvs Pharma Ltd vs Vivanza Biosciences Ltd Stock Comparison

Last Updated on: May 20, 2025

Key Highlights

  • The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 121.7 as of 20 May 09:59.
  • The P/E Ratio of Bliss GVS Pharma Ltd changed from 10.7 on March 2020 to 15.6 on March 2024 . This represents a CAGR of 7.83% over 5 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 48.5 on March 2024 . This represents a CAGR of -48.46% over 4 years.
  • The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1039 crore on March 2020 to ₹ 1179 crore on March 2024 . This represents a CAGR of 2.55% over 5 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 27.16 crore on March 2024 . This represents a CAGR of -15.09% over 4 years.
  • The revenue of Bliss GVS Pharma Ltd for the Mar '25 is ₹ 210.05 crore as compare to the Dec '24 revenue of ₹ 225.68 crore. This represent the decline of -6.93% The revenue of Vivanza Biosciences Ltd for the Mar '25 is ₹ 0.53 crore as compare to the Dec '24 revenue of ₹ 1.51 crore. This represent the decline of -64.9%.
  • The ebitda of Bliss GVS Pharma Ltd for the Mar '25 is ₹ 33.15 crore as compare to the Dec '24 ebitda of ₹ 45.05 crore. This represent the decline of -26.42% The ebitda of Vivanza Biosciences Ltd for the Mar '25 is ₹ -0.91 crore as compare to the Dec '24 ebitda of ₹ 0.13 crore. This represent the decline of -800%.
  • The net profit of Bliss GVS Pharma Ltd changed from ₹ 14.37 crore to ₹ 16.65 crore over 8 quarters. This represents a CAGR of 7.64% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.49 crore to ₹ -1 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Bliss GVS Pharma Ltd changed from 5.58 % on March 2020 to 10.34 % on March 2024 . This represents a CAGR of 13.13% over 5 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
  • The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
  • It has a strong foothold in Sub Saharan Africa.
  • The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

About Vivanza Biosciences Ltd

  • Vivanza Biosciences Limited(Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
  • Due to recessionary trends which lead to difficult business conditions in the year 1999-2000, the parenteral industry suffered a setback.
  • As a result of this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines.
  • It is presently engaged in the business of Pharmaceutical Products and Pharma Products. Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma schedules AGM

Bliss GVS Pharma announced that the 40th Annual General Meeting(AGM) of the company will b...

Read more

13 May 2025 12:51

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

13 May 2025 09:26

News

Bliss GVS Pharma to announce Quarterly Result

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 12 May 20...

Read more

06 May 2025 11:50

News

Bliss GVS Pharma invokes arbitration proceedings against Pan Pharmaceuticals, Kenya

Bliss GVS Pharma had invoked arbitration proceedings against Pan Pharmaceuticals (Nairobi,...

Read more

03 May 2025 11:27

News

Bliss GVS Pharma schedules board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 Januar...

Read more

22 Jan 2025 09:41

News

Bliss GVS Pharma allots 34,250 equity shares under ESOP

Bliss GVS Pharma has allotted 34,250 equity shares under ESOP on 06 December 2024. With th...

Read more

06 Dec 2024 19:02

Vivanza Biosciences Ltd News Hub

News

Vivanza Biosciences to table results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 May...

Read more

08 May 2025 11:19

News

Vivanza Biosciences announces board meeting date

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 May...

Read more

07 May 2025 11:35

News

Vivanza Biosciences to discuss results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 31 Jan...

Read more

25 Jan 2025 10:18

News

Vivanza Biosciences to declare Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 17 Oct...

Read more

11 Oct 2024 10:17

News

Vivanza Biosciences to announce Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 8 Augu...

Read more

03 Aug 2024 17:02

News

Vivanza Biosciences to convene AGM

Vivanza Biosciences announced that the 42nd Annual General Meeting (AGM) of the company wi...

Read more

08 Jul 2024 10:49

SWOT Analysis Of Vivanza Biosciences Ltd

Strength

2

S

Weakness

3

W

Opportunity

1

O

Threats

0

T

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Vivanza Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bliss GVS Pharma Ltd and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Bliss GVS Pharma Ltd or Vivanza Biosciences Ltd?

Market cap of Bliss GVS Pharma Ltd is 1,307 Cr while Market cap of Vivanza Biosciences Ltd is 10 Cr

What are the key factors driving the stock performance of Bliss GVS Pharma Ltd and Vivanza Biosciences Ltd?

The stock performance of Bliss GVS Pharma Ltd and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bliss GVS Pharma Ltd and Vivanza Biosciences Ltd?

As of May 20, 2025, the Bliss GVS Pharma Ltd stock price is INR ₹124.05. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹2.54.

How do dividend payouts of Bliss GVS Pharma Ltd and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Bliss GVS Pharma Ltd and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions